Clinical trial
Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation (E3) Trial
NCT02417467 is registered in ClinicalTrials.gov with McGill University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation (E3) Trial
- Lead sponsor
- McGill University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- October 1, 2020
- Enrollment
- 376 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
smoking cessation